Qianyi, W., Mei, X., Rui, Z., Yong, W., Yutao, W., Xiaoding, S., & Xiaoting, W. (2022). Delayed adjuvant imatinib in patients with high risk of recurrence of gastrointestinal stromal tumor after radical surgery: A retrospective cohort study. Journal of cancer research and clinical oncology, 148(6), 1493-1500. https://doi.org/10.1007/s00432-021-03749-6
Citácia podle Chicago (17th ed.)Qianyi, Wan, Xu Mei, Zhao Rui, Wang Yong, Wu Yutao, Shen Xiaoding, a Wu Xiaoting. "Delayed Adjuvant Imatinib in Patients with High Risk of Recurrence of Gastrointestinal Stromal Tumor After Radical Surgery: A Retrospective Cohort Study." Journal of Cancer Research and Clinical Oncology 148, no. 6 (2022): 1493-1500. https://doi.org/10.1007/s00432-021-03749-6.
Citácia podľa MLA (8th ed.)Qianyi, Wan, et al. "Delayed Adjuvant Imatinib in Patients with High Risk of Recurrence of Gastrointestinal Stromal Tumor After Radical Surgery: A Retrospective Cohort Study." Journal of Cancer Research and Clinical Oncology, vol. 148, no. 6, 2022, pp. 1493-1500, https://doi.org/10.1007/s00432-021-03749-6.